Precise Metabolomics Defines Systemic Metabolic Dysregulation Distinct to Acute Myocardial Infarction Associated With Diabetes.
Jing-Gang XiaBowen LiHao ZhangQin-Xue LiSin Man LamChun-Lin YinHe TianGuang-Hou ShuiPublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
As circulating metabolite levels are amenable to therapeutic intervention, such shifts in metabolic signatures provide new clues and potential therapeutic targets specific to the treatment of diabetes-AMI.
Keyphrases
- acute myocardial infarction
- type diabetes
- cardiovascular disease
- glycemic control
- percutaneous coronary intervention
- randomized controlled trial
- mass spectrometry
- left ventricular
- coronary artery disease
- heart failure
- risk assessment
- gene expression
- adipose tissue
- insulin resistance
- combination therapy
- human health
- metabolic syndrome
- weight loss